FDA Approved: MYALEPT — Supplemental Application (Chiesi USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for MYALEPT (metreleptin) filed by Chiesi USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Generalized Lipodystrophy
• Familial Partial Lipodystrophy

Drugs mentioned

• MYALEPT (METRELEPTIN)

Snippet

SUPPL AP for MYALEPT (METRELEPTIN)